Merdad Parsey
Chief Tech/Sci/R&D Officer presso GILEAD SCIENCES, INC.
Patrimonio netto: 7 M $ in data 31/03/2024
Profilo
Il Dr. Merdad V. Parsey è un amministratore indipendente di Arcus Biosciences, Inc. e un Chief Medical Officer di Gilead Sciences, Inc. Fa parte del Consiglio di amministrazione di Arcus Biosciences, Inc. e Sagimet Biosciences, Inc. Il Dr. Parsey è stato precedentemente impiegato come direttore medico senior presso Regeneron Pharmaceuticals, Inc., come direttore senior del gruppo medico presso Genentech, Inc., come direttore medico associato presso Merck & Co., Inc., come direttore di medicina critica presso la New York University School of Medicine, come membro del Roche Group e come direttore medico senior presso Sunovion Pharmaceuticals, Inc. Ha ricevuto il suo dottorato dall'Università del Maryland.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
GILEAD SCIENCES, INC.
0.01% | 01/04/2024 | 96 304 ( 0.01% ) | 7 M $ | 31/03/2024 |
18/07/2023 | 12 794 ( 0.06% ) | 69 343 $ | 31/03/2024 |
Posizioni attive di Merdad Parsey
Società | Posizione | Inizio |
---|---|---|
SAGIMET BIOSCIENCES INC. | Director/Board Member | 30/09/2010 |
GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/11/2019 |
ARCUS BIOSCIENCES, INC. | Director/Board Member | 13/07/2020 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Director/Board Member | - |
Precedenti posizioni note di Merdad Parsey
Società | Posizione | Fine |
---|---|---|
REGENERON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2004 |
New York University School of Medicine | Corporate Officer/Principal | - |
MERCK & CO., INC. | Corporate Officer/Principal | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Chief Tech/Sci/R&D Officer | - |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formazione di Merdad Parsey
University of Maryland | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
REGENERON PHARMACEUTICALS, INC. | Health Technology |
SAGIMET BIOSCIENCES INC. | Health Technology |
ARCUS BIOSCIENCES, INC. | Health Technology |
Aziende private | 4 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
- Borsa valori
- Insiders
- Merdad Parsey